ENPP2 and Hepatic fibrosis: Regarding HCC, pharmacological inhibition of ATX resulted in decreased histological fibrosis and reduced HCC development in a DEN model of hepatic fibrosis and HCC, that has been shown to closely resemble human disease [152,155] and in a mouse model of PSC which also develops HCC [216,239].